nodes	percent_of_prediction	percent_of_DWPC	metapath
Erlotinib—STK10—renal vein—abdominal aortic aneurysm	0.225	0.33	CbGeAlD
Erlotinib—STK10—renal artery—abdominal aortic aneurysm	0.152	0.222	CbGeAlD
Erlotinib—FLT3—blood plasma—abdominal aortic aneurysm	0.0332	0.0486	CbGeAlD
Erlotinib—JAK3—connective tissue—abdominal aortic aneurysm	0.0224	0.0328	CbGeAlD
Erlotinib—STK10—blood plasma—abdominal aortic aneurysm	0.0222	0.0325	CbGeAlD
Erlotinib—UGT1A1—blood plasma—abdominal aortic aneurysm	0.0209	0.0307	CbGeAlD
Erlotinib—FLT3—connective tissue—abdominal aortic aneurysm	0.0177	0.0259	CbGeAlD
Erlotinib—PIP4K2C—spinal cord—abdominal aortic aneurysm	0.0106	0.0155	CbGeAlD
Erlotinib—ULK3—spinal cord—abdominal aortic aneurysm	0.0101	0.0148	CbGeAlD
Erlotinib—STK10—kidney—abdominal aortic aneurysm	0.0101	0.0147	CbGeAlD
Erlotinib—CYP2C8—blood plasma—abdominal aortic aneurysm	0.00991	0.0145	CbGeAlD
Erlotinib—MKNK1—spinal cord—abdominal aortic aneurysm	0.00951	0.0139	CbGeAlD
Erlotinib—UGT1A1—kidney—abdominal aortic aneurysm	0.0095	0.0139	CbGeAlD
Erlotinib—CYP1A2—blood plasma—abdominal aortic aneurysm	0.00928	0.0136	CbGeAlD
Erlotinib—SLK—spinal cord—abdominal aortic aneurysm	0.009	0.0132	CbGeAlD
Erlotinib—CYP3A5—blood plasma—abdominal aortic aneurysm	0.00895	0.0131	CbGeAlD
Erlotinib—ABL1—connective tissue—abdominal aortic aneurysm	0.00814	0.0119	CbGeAlD
Erlotinib—MAP2K5—spinal cord—abdominal aortic aneurysm	0.00699	0.0102	CbGeAlD
Erlotinib—SLCO2B1—kidney—abdominal aortic aneurysm	0.00699	0.0102	CbGeAlD
Erlotinib—ABL1—kidney—abdominal aortic aneurysm	0.00693	0.0101	CbGeAlD
Erlotinib—CYP1B1—connective tissue—abdominal aortic aneurysm	0.00689	0.0101	CbGeAlD
Erlotinib—CYP3A4—blood plasma—abdominal aortic aneurysm	0.00671	0.00984	CbGeAlD
Erlotinib—CYP2D6—blood plasma—abdominal aortic aneurysm	0.00661	0.00968	CbGeAlD
Erlotinib—CYP1B1—kidney—abdominal aortic aneurysm	0.00587	0.00859	CbGeAlD
Erlotinib—ORM1—spinal cord—abdominal aortic aneurysm	0.00568	0.00832	CbGeAlD
Erlotinib—SLCO2B1—spinal cord—abdominal aortic aneurysm	0.00544	0.00797	CbGeAlD
Erlotinib—ABL1—spinal cord—abdominal aortic aneurysm	0.00539	0.0079	CbGeAlD
Erlotinib—ABCB1—blood plasma—abdominal aortic aneurysm	0.00475	0.00696	CbGeAlD
Erlotinib—CYP2C8—kidney—abdominal aortic aneurysm	0.00449	0.00658	CbGeAlD
Erlotinib—CYP1A1—kidney—abdominal aortic aneurysm	0.00415	0.00607	CbGeAlD
Erlotinib—CYP3A5—kidney—abdominal aortic aneurysm	0.00405	0.00594	CbGeAlD
Erlotinib—ABCG2—spinal cord—abdominal aortic aneurysm	0.0034	0.00498	CbGeAlD
Erlotinib—CYP3A4—kidney—abdominal aortic aneurysm	0.00304	0.00446	CbGeAlD
Erlotinib—CYP2D6—kidney—abdominal aortic aneurysm	0.00299	0.00439	CbGeAlD
Erlotinib—ABCB1—kidney—abdominal aortic aneurysm	0.00215	0.00316	CbGeAlD
Erlotinib—ABCB1—spinal cord—abdominal aortic aneurysm	0.00168	0.00246	CbGeAlD
Erlotinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—abdominal aortic aneurysm	0.000865	0.00273	CbGpPWpGaD
Erlotinib—ALB—Selenium Micronutrient Network—SOD2—abdominal aortic aneurysm	0.000857	0.0027	CbGpPWpGaD
Erlotinib—ABL2—Axon guidance—MMP9—abdominal aortic aneurysm	0.000856	0.0027	CbGpPWpGaD
Erlotinib—ALB—Vitamin B12 Metabolism—SERPINE1—abdominal aortic aneurysm	0.000852	0.00269	CbGpPWpGaD
Erlotinib—MKNK1—Disease—LDLR—abdominal aortic aneurysm	0.000852	0.00269	CbGpPWpGaD
Erlotinib—ABL1—Hemostasis—P2RY12—abdominal aortic aneurysm	0.000839	0.00264	CbGpPWpGaD
Erlotinib—CYP2D6—Melatonin metabolism and effects—NFKB1—abdominal aortic aneurysm	0.000838	0.00264	CbGpPWpGaD
Erlotinib—CYP1A1—Arachidonic acid metabolism—PTGS2—abdominal aortic aneurysm	0.00083	0.00261	CbGpPWpGaD
Erlotinib—ABL2—Developmental Biology—MMP2—abdominal aortic aneurysm	0.000813	0.00256	CbGpPWpGaD
Erlotinib—EGFR—Spinal Cord Injury—CCL2—abdominal aortic aneurysm	0.00081	0.00255	CbGpPWpGaD
Erlotinib—MAP2K5—MAPK Signaling Pathway—NFKB1—abdominal aortic aneurysm	0.000805	0.00254	CbGpPWpGaD
Erlotinib—ALB—Platelet activation, signaling and aggregation—P2RY12—abdominal aortic aneurysm	0.000801	0.00252	CbGpPWpGaD
Erlotinib—JAK3—Immune System—AAAS—abdominal aortic aneurysm	0.000797	0.00251	CbGpPWpGaD
Erlotinib—MKNK1—Disease—NCF1—abdominal aortic aneurysm	0.000797	0.00251	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.000788	0.00248	CbGpPWpGaD
Erlotinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—abdominal aortic aneurysm	0.000771	0.00243	CbGpPWpGaD
Erlotinib—CYP1A1—Aryl Hydrocarbon Receptor—NFKB1—abdominal aortic aneurysm	0.00077	0.00243	CbGpPWpGaD
Erlotinib—CYP2C8—Arachidonic acid metabolism—PTGS2—abdominal aortic aneurysm	0.000761	0.0024	CbGpPWpGaD
Erlotinib—ALB—Folate Metabolism—CCL2—abdominal aortic aneurysm	0.000743	0.00234	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000737	0.00232	CbGpPWpGaD
Erlotinib—EPHA6—Axon guidance—MMP9—abdominal aortic aneurysm	0.000722	0.00227	CbGpPWpGaD
Erlotinib—ABCB1—HIF-1-alpha transcription factor network—NOS2—abdominal aortic aneurysm	0.000722	0.00227	CbGpPWpGaD
Erlotinib—ABL1—DNA Damage Response (only ATM dependent)—NFKB1—abdominal aortic aneurysm	0.000715	0.00225	CbGpPWpGaD
Erlotinib—CYP1A2—Melatonin metabolism and effects—NFKB1—abdominal aortic aneurysm	0.00071	0.00224	CbGpPWpGaD
Erlotinib—ALB—Folate Metabolism—SERPINE1—abdominal aortic aneurysm	0.000694	0.00219	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—SELL—abdominal aortic aneurysm	0.000688	0.00217	CbGpPWpGaD
Erlotinib—NR1I2—Generic Transcription Pathway—SERPINE1—abdominal aortic aneurysm	0.000687	0.00217	CbGpPWpGaD
Erlotinib—EPHA6—Developmental Biology—MMP2—abdominal aortic aneurysm	0.000685	0.00216	CbGpPWpGaD
Erlotinib—EGFR—Direct p53 effectors—MMP2—abdominal aortic aneurysm	0.000672	0.00212	CbGpPWpGaD
Erlotinib—EGFR—Spinal Cord Injury—PTGS2—abdominal aortic aneurysm	0.000661	0.00208	CbGpPWpGaD
Erlotinib—EGFR—Direct p53 effectors—SERPINE1—abdominal aortic aneurysm	0.00066	0.00208	CbGpPWpGaD
Erlotinib—CYP1A1—PPARA activates gene expression—AGT—abdominal aortic aneurysm	0.000658	0.00207	CbGpPWpGaD
Erlotinib—JAK3—Cytokine Signaling in Immune system—NFKB1—abdominal aortic aneurysm	0.000656	0.00207	CbGpPWpGaD
Erlotinib—ALB—SLC-mediated transmembrane transport—AAAS—abdominal aortic aneurysm	0.000653	0.00206	CbGpPWpGaD
Erlotinib—JAK3—Immune System—NCF1—abdominal aortic aneurysm	0.000651	0.00205	CbGpPWpGaD
Erlotinib—ALB—Vitamin B12 Metabolism—NFKB1—abdominal aortic aneurysm	0.000646	0.00204	CbGpPWpGaD
Erlotinib—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—abdominal aortic aneurysm	0.000644	0.00203	CbGpPWpGaD
Erlotinib—JAK3—Hemostasis—NOS2—abdominal aortic aneurysm	0.000641	0.00202	CbGpPWpGaD
Erlotinib—JAK3—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.00063	0.00199	CbGpPWpGaD
Erlotinib—ABL2—Developmental Biology—MMP9—abdominal aortic aneurysm	0.000611	0.00192	CbGpPWpGaD
Erlotinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—abdominal aortic aneurysm	0.000609	0.00192	CbGpPWpGaD
Erlotinib—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—abdominal aortic aneurysm	0.000608	0.00191	CbGpPWpGaD
Erlotinib—ABL2—Developmental Biology—NFKB1—abdominal aortic aneurysm	0.000604	0.0019	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000597	0.00188	CbGpPWpGaD
Erlotinib—ALB—Platelet degranulation—SERPINE1—abdominal aortic aneurysm	0.000595	0.00187	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.000594	0.00187	CbGpPWpGaD
Erlotinib—ALB—Selenium Micronutrient Network—CCL2—abdominal aortic aneurysm	0.00059	0.00186	CbGpPWpGaD
Erlotinib—EGFR—Spinal Cord Injury—MMP9—abdominal aortic aneurysm	0.000579	0.00183	CbGpPWpGaD
Erlotinib—JAK3—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.000572	0.0018	CbGpPWpGaD
Erlotinib—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—abdominal aortic aneurysm	0.000567	0.00178	CbGpPWpGaD
Erlotinib—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—abdominal aortic aneurysm	0.000565	0.00178	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000558	0.00176	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000556	0.00175	CbGpPWpGaD
Erlotinib—ALB—Selenium Micronutrient Network—SERPINE1—abdominal aortic aneurysm	0.000551	0.00174	CbGpPWpGaD
Erlotinib—ABL1—Integrated Breast Cancer Pathway—NFKB1—abdominal aortic aneurysm	0.000551	0.00174	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism of lipids and lipoproteins—LDLR—abdominal aortic aneurysm	0.000543	0.00171	CbGpPWpGaD
Erlotinib—JAK3—Hemostasis—SERPINE1—abdominal aortic aneurysm	0.00054	0.0017	CbGpPWpGaD
Erlotinib—ABCG2—Transmembrane transport of small molecules—AAAS—abdominal aortic aneurysm	0.000538	0.00169	CbGpPWpGaD
Erlotinib—CYP1A2—Arachidonic acid metabolism—PTGS2—abdominal aortic aneurysm	0.000529	0.00167	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling by NGF—NFKB1—abdominal aortic aneurysm	0.000526	0.00166	CbGpPWpGaD
Erlotinib—ABL1—Integrated Pancreatic Cancer Pathway—PTGS2—abdominal aortic aneurysm	0.000526	0.00166	CbGpPWpGaD
Erlotinib—ALB—Folate Metabolism—NFKB1—abdominal aortic aneurysm	0.000526	0.00166	CbGpPWpGaD
Erlotinib—EPHA6—Developmental Biology—MMP9—abdominal aortic aneurysm	0.000515	0.00162	CbGpPWpGaD
Erlotinib—JAK3—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.00051	0.00161	CbGpPWpGaD
Erlotinib—EPHA6—Developmental Biology—NFKB1—abdominal aortic aneurysm	0.00051	0.00161	CbGpPWpGaD
Erlotinib—EGFR—Signaling by SCF-KIT—MMP9—abdominal aortic aneurysm	0.000502	0.00158	CbGpPWpGaD
Erlotinib—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—abdominal aortic aneurysm	0.000491	0.00155	CbGpPWpGaD
Erlotinib—ABL1—Immune System—SELL—abdominal aortic aneurysm	0.000489	0.00154	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.000484	0.00153	CbGpPWpGaD
Erlotinib—ALB—Selenium Micronutrient Network—PTGS2—abdominal aortic aneurysm	0.000481	0.00152	CbGpPWpGaD
Erlotinib—EGFR—Integrated Breast Cancer Pathway—NFKB1—abdominal aortic aneurysm	0.000471	0.00148	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—NCF1—abdominal aortic aneurysm	0.00047	0.00148	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—SELL—abdominal aortic aneurysm	0.000459	0.00145	CbGpPWpGaD
Erlotinib—ABL1—Integrated Pancreatic Cancer Pathway—NFKB1—abdominal aortic aneurysm	0.000456	0.00144	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000453	0.00143	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.00045	0.00142	CbGpPWpGaD
Erlotinib—EGFR—Integrated Pancreatic Cancer Pathway—PTGS2—abdominal aortic aneurysm	0.000449	0.00142	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000448	0.00141	CbGpPWpGaD
Erlotinib—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—abdominal aortic aneurysm	0.000443	0.0014	CbGpPWpGaD
Erlotinib—JAK3—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.000443	0.0014	CbGpPWpGaD
Erlotinib—MKNK1—Disease—APOE—abdominal aortic aneurysm	0.000441	0.00139	CbGpPWpGaD
Erlotinib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—abdominal aortic aneurysm	0.000434	0.00137	CbGpPWpGaD
Erlotinib—EGFR—MAPK Signaling Pathway—NFKB1—abdominal aortic aneurysm	0.000432	0.00136	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000421	0.00133	CbGpPWpGaD
Erlotinib—ALB—Selenium Micronutrient Network—NFKB1—abdominal aortic aneurysm	0.000418	0.00132	CbGpPWpGaD
Erlotinib—EGFR—Immune System—SELL—abdominal aortic aneurysm	0.000417	0.00132	CbGpPWpGaD
Erlotinib—EGFR—Fc epsilon receptor (FCERI) signaling—NFKB1—abdominal aortic aneurysm	0.000414	0.00131	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—P2RY12—abdominal aortic aneurysm	0.000413	0.0013	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—P2RY12—abdominal aortic aneurysm	0.000411	0.0013	CbGpPWpGaD
Erlotinib—MKNK1—Disease—NOS2—abdominal aortic aneurysm	0.000411	0.0013	CbGpPWpGaD
Erlotinib—ABL1—Immune System—AAAS—abdominal aortic aneurysm	0.000408	0.00129	CbGpPWpGaD
Erlotinib—JAK3—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.000403	0.00127	CbGpPWpGaD
Erlotinib—ABL1—Axon guidance—MMP2—abdominal aortic aneurysm	0.000402	0.00127	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.0004	0.00126	CbGpPWpGaD
Erlotinib—EGFR—Integrated Pancreatic Cancer Pathway—NFKB1—abdominal aortic aneurysm	0.00039	0.00123	CbGpPWpGaD
Erlotinib—EGFR—B Cell Activation—NFKB1—abdominal aortic aneurysm	0.000384	0.00121	CbGpPWpGaD
Erlotinib—EGFR—Disease—LRP1—abdominal aortic aneurysm	0.000371	0.00117	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000367	0.00116	CbGpPWpGaD
Erlotinib—EGFR—Immune System—AAAS—abdominal aortic aneurysm	0.000349	0.0011	CbGpPWpGaD
Erlotinib—MKNK1—Disease—SERPINE1—abdominal aortic aneurysm	0.000346	0.00109	CbGpPWpGaD
Erlotinib—EGFR—Axon guidance—MMP2—abdominal aortic aneurysm	0.000344	0.00108	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000343	0.00108	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000338	0.00107	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism of lipids and lipoproteins—LDLR—abdominal aortic aneurysm	0.000334	0.00105	CbGpPWpGaD
Erlotinib—ABL1—Immune System—NCF1—abdominal aortic aneurysm	0.000333	0.00105	CbGpPWpGaD
Erlotinib—ALB—Transmembrane transport of small molecules—AAAS—abdominal aortic aneurysm	0.000332	0.00105	CbGpPWpGaD
Erlotinib—JAK3—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.000332	0.00105	CbGpPWpGaD
Erlotinib—NR1I2—Gene Expression—SERPINE1—abdominal aortic aneurysm	0.000331	0.00104	CbGpPWpGaD
Erlotinib—ABL1—Hemostasis—NOS2—abdominal aortic aneurysm	0.000328	0.00103	CbGpPWpGaD
Erlotinib—EGFR—Disease—AAAS—abdominal aortic aneurysm	0.000322	0.00101	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000315	0.000994	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000309	0.000974	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—LDLR—abdominal aortic aneurysm	0.000306	0.000965	CbGpPWpGaD
Erlotinib—ALB—Metabolism of lipids and lipoproteins—LDLR—abdominal aortic aneurysm	0.000305	0.00096	CbGpPWpGaD
Erlotinib—MKNK1—Disease—PTGS2—abdominal aortic aneurysm	0.000302	0.000953	CbGpPWpGaD
Erlotinib—ABL1—Axon guidance—MMP9—abdominal aortic aneurysm	0.000302	0.000952	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000301	0.000949	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—AAAS—abdominal aortic aneurysm	0.000297	0.000935	CbGpPWpGaD
Erlotinib—ABCB1—Transmembrane transport of small molecules—AAAS—abdominal aortic aneurysm	0.000291	0.000916	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—MMP2—abdominal aortic aneurysm	0.000287	0.000904	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	0.000287	0.000904	CbGpPWpGaD
Erlotinib—EGFR—Immune System—NCF1—abdominal aortic aneurysm	0.000285	0.000898	CbGpPWpGaD
Erlotinib—EGFR—Signaling by NGF—NFKB1—abdominal aortic aneurysm	0.000282	0.00089	CbGpPWpGaD
Erlotinib—EGFR—Disease—LDLR—abdominal aortic aneurysm	0.000281	0.000886	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	0.000281	0.000885	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—AAAS—abdominal aortic aneurysm	0.000277	0.000872	CbGpPWpGaD
Erlotinib—ABL1—Hemostasis—SERPINE1—abdominal aortic aneurysm	0.000276	0.00087	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000276	0.000868	CbGpPWpGaD
Erlotinib—ALB—Platelet activation, signaling and aggregation—SERPINE1—abdominal aortic aneurysm	0.000264	0.000831	CbGpPWpGaD
Erlotinib—EGFR—Disease—NCF1—abdominal aortic aneurysm	0.000263	0.000829	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.00026	0.000819	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.00026	0.000819	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—LDLR—abdominal aortic aneurysm	0.000259	0.000816	CbGpPWpGaD
Erlotinib—EGFR—Axon guidance—MMP9—abdominal aortic aneurysm	0.000258	0.000814	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—AAAS—abdominal aortic aneurysm	0.000252	0.000793	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.00025	0.000789	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000246	0.000774	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—MMP2—abdominal aortic aneurysm	0.000245	0.000773	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000243	0.000766	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000243	0.000764	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—LDLR—abdominal aortic aneurysm	0.000242	0.000761	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000238	0.00075	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000233	0.000734	CbGpPWpGaD
Erlotinib—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—abdominal aortic aneurysm	0.000227	0.000715	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.000223	0.000703	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—LDLR—abdominal aortic aneurysm	0.00022	0.000693	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—MMP9—abdominal aortic aneurysm	0.000216	0.00068	CbGpPWpGaD
Erlotinib—JAK3—Immune System—NFKB1—abdominal aortic aneurysm	0.000214	0.000676	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—NFKB1—abdominal aortic aneurysm	0.000213	0.000672	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—LDLR—abdominal aortic aneurysm	0.000213	0.000671	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000197	0.00062	CbGpPWpGaD
Erlotinib—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—abdominal aortic aneurysm	0.000197	0.00062	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000196	0.000617	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000194	0.000611	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	0.000193	0.000607	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—APOE—abdominal aortic aneurysm	0.00019	0.000599	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—NFKB1—abdominal aortic aneurysm	0.000188	0.000594	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000186	0.000585	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—MMP9—abdominal aortic aneurysm	0.000184	0.000581	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000184	0.00058	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000184	0.000579	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000183	0.000576	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—NFKB1—abdominal aortic aneurysm	0.000182	0.000575	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—AAAS—abdominal aortic aneurysm	0.00018	0.000568	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	0.000177	0.000556	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.000176	0.000555	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	0.000173	0.000545	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—AAAS—abdominal aortic aneurysm	0.00017	0.000537	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	0.000162	0.00051	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—NOS2—abdominal aortic aneurysm	0.000161	0.000509	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—NFKB1—abdominal aortic aneurysm	0.000161	0.000507	CbGpPWpGaD
Erlotinib—ALB—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	0.000161	0.000507	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.00016	0.000503	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	0.000159	0.0005	CbGpPWpGaD
Erlotinib—ALB—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	0.000158	0.000497	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—LDLR—abdominal aortic aneurysm	0.000158	0.000496	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—AAAS—abdominal aortic aneurysm	0.000156	0.000492	CbGpPWpGaD
Erlotinib—ALB—Metabolism—AAAS—abdominal aortic aneurysm	0.000155	0.00049	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—NFKB1—abdominal aortic aneurysm	0.000155	0.000487	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000149	0.00047	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—LDLR—abdominal aortic aneurysm	0.000149	0.000469	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000148	0.000466	CbGpPWpGaD
Erlotinib—EGFR—Disease—APOE—abdominal aortic aneurysm	0.000146	0.000459	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.000145	0.000457	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.00014	0.000441	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000139	0.000437	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—AGT—abdominal aortic aneurysm	0.000137	0.000431	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—LDLR—abdominal aortic aneurysm	0.000136	0.00043	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—AAAS—abdominal aortic aneurysm	0.000136	0.000429	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—SERPINE1—abdominal aortic aneurysm	0.000136	0.000428	CbGpPWpGaD
Erlotinib—EGFR—Disease—NOS2—abdominal aortic aneurysm	0.000136	0.000428	CbGpPWpGaD
Erlotinib—ALB—Metabolism—LDLR—abdominal aortic aneurysm	0.000136	0.000427	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—APOE—abdominal aortic aneurysm	0.000134	0.000423	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000132	0.000415	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—AAAS—abdominal aortic aneurysm	0.000128	0.000404	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—AGT—abdominal aortic aneurysm	0.000128	0.000402	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—APOE—abdominal aortic aneurysm	0.000125	0.000394	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—LDLR—abdominal aortic aneurysm	0.000119	0.000375	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	0.000119	0.000374	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—AGT—abdominal aortic aneurysm	0.000116	0.000366	CbGpPWpGaD
Erlotinib—EGFR—Disease—SERPINE1—abdominal aortic aneurysm	0.000114	0.00036	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000114	0.00036	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—APOE—abdominal aortic aneurysm	0.000114	0.000359	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000113	0.000356	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	0.000113	0.000355	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—LDLR—abdominal aortic aneurysm	0.000112	0.000353	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	0.00011	0.000348	CbGpPWpGaD
Erlotinib—ABL1—Immune System—NFKB1—abdominal aortic aneurysm	0.00011	0.000346	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	0.000109	0.000343	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—AAAS—abdominal aortic aneurysm	0.000109	0.000342	CbGpPWpGaD
Erlotinib—ALB—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	0.000108	0.000341	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000104	0.000328	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000102	0.000321	CbGpPWpGaD
Erlotinib—EGFR—Disease—PTGS2—abdominal aortic aneurysm	9.98e-05	0.000314	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—LDLR—abdominal aortic aneurysm	9.49e-05	0.000299	CbGpPWpGaD
Erlotinib—EGFR—Immune System—NFKB1—abdominal aortic aneurysm	9.38e-05	0.000296	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—PTGS2—abdominal aortic aneurysm	9.19e-05	0.00029	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—PTGS2—abdominal aortic aneurysm	8.57e-05	0.00027	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CCL2—abdominal aortic aneurysm	8.57e-05	0.00027	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—AAAS—abdominal aortic aneurysm	8.39e-05	0.000264	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—AGT—abdominal aortic aneurysm	8.33e-05	0.000262	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—APOE—abdominal aortic aneurysm	8.16e-05	0.000257	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	8e-05	0.000252	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—AGT—abdominal aortic aneurysm	7.87e-05	0.000248	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—PTGS2—abdominal aortic aneurysm	7.8e-05	0.000246	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—APOE—abdominal aortic aneurysm	7.71e-05	0.000243	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	7.56e-05	0.000238	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—LDLR—abdominal aortic aneurysm	7.32e-05	0.000231	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—AGT—abdominal aortic aneurysm	7.21e-05	0.000227	CbGpPWpGaD
Erlotinib—ALB—Metabolism—AGT—abdominal aortic aneurysm	7.17e-05	0.000226	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—APOE—abdominal aortic aneurysm	7.07e-05	0.000223	CbGpPWpGaD
Erlotinib—ALB—Metabolism—APOE—abdominal aortic aneurysm	7.03e-05	0.000221	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—AGT—abdominal aortic aneurysm	6.28e-05	0.000198	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—APOE—abdominal aortic aneurysm	6.16e-05	0.000194	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—MMP9—abdominal aortic aneurysm	6.13e-05	0.000193	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—NFKB1—abdominal aortic aneurysm	6.06e-05	0.000191	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—AGT—abdominal aortic aneurysm	5.92e-05	0.000187	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—APOE—abdominal aortic aneurysm	5.8e-05	0.000183	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—PTGS2—abdominal aortic aneurysm	5.59e-05	0.000176	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—PTGS2—abdominal aortic aneurysm	5.28e-05	0.000166	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—AGT—abdominal aortic aneurysm	5.02e-05	0.000158	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—APOE—abdominal aortic aneurysm	4.91e-05	0.000155	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—PTGS2—abdominal aortic aneurysm	4.84e-05	0.000153	CbGpPWpGaD
Erlotinib—ALB—Metabolism—PTGS2—abdominal aortic aneurysm	4.81e-05	0.000152	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—PTGS2—abdominal aortic aneurysm	4.22e-05	0.000133	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PTGS2—abdominal aortic aneurysm	3.97e-05	0.000125	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—AGT—abdominal aortic aneurysm	3.87e-05	0.000122	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—APOE—abdominal aortic aneurysm	3.79e-05	0.000119	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PTGS2—abdominal aortic aneurysm	3.37e-05	0.000106	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PTGS2—abdominal aortic aneurysm	2.6e-05	8.19e-05	CbGpPWpGaD
